Relevant Clinical Trials

Pneumatic Retinopexy for Repair of Rhegmatogenous Retinal Detachment

Pneumatic Retinopexy for Repair of Rhegmatogenous Retinal Detachment

Dr. Rezaei discusses the outcomes of patients who underwent primary pneuma…

Expiration Date: 9/29/2015

Max Credits: 0

View Activity

Update on ARGUS II

Update on ARGUS II

The Argus II retinal prosthesis has been shown to improve the capabilities…

Expiration Date: 3/4/2015

Max Credits: 0

View Activity

Contemporary Management of Diseases of the Vitreomacular Interface

Contemporary Management of Diseases of the Vitreomacular Interface

The topic is Ocriplasmin in Clinical Practice, and we now have experience …

Expiration Date: 12/17/2014

Max Credits: 0

View Activity

Long-term Outcomes with Ocriplasmin

Long-term Outcomes with Ocriplasmin

I am going to talk about ocriplasmin’s clinical trial, specifically phase …

Expiration Date: 7/31/2014

Max Credits: 0

View Activity

COMPLETE Study Results on the Systemic Complement Inhibitor Eculizumab In AMD Patients With Drusen

COMPLETE Study Results on the Systemic Complement Inhibitor Eculizumab In AMD Patients With Drusen

The COMPLETE Study is the first use of systemic complement inhibition for …

Expiration Date: 5/10/2014

Max Credits: 0

View Activity

On the Scene at ARVO: Interview with Baruch D. Kuppermann, MD, PhD

On the Scene at ARVO: Interview with Baruch D. Kuppermann, MD, PhD

A single intravitreal dose of 125 µg of ocriplasmin achieved resolution of…

Expiration Date: 5/17/2015

Max Credits: 0

View Activity

What Are the Long-Term Effects of Ranibizumab on Diabetic Retinopathy?

What Are the Long-Term Effects of Ranibizumab on Diabetic Retinopathy?

Intravitreal RBZ reduced the risk and rate of DR progression in eyes with …

Expiration Date: 5/17/2015

Max Credits: 0

View Activity

Are There Anatomic Predictors of Response to Anti-VEGF Therapy?

Are There Anatomic Predictors of Response to Anti-VEGF Therapy?

Early OCT Responses at Day 7 and Month 1 Post Ranibizumab That Predict Vis…

Expiration Date: 8/26/2015

Max Credits: 0

View Activity

Update on Novel Oral Therapy for DME

Update on Novel Oral Therapy for DME

Administered systemically, ASP-440 is a selective, safe and efficacious in…

Expiration Date: 5/31/2015

Max Credits: 0

View Activity

Does Aspirin Increase Risk of AMD or Disease Progression?

Does Aspirin Increase Risk of AMD or Disease Progression?

The observational AREDS2 results demonstrate an inverse relationship betwe…

Expiration Date: 5/31/2015

Max Credits: 0

View Activity